Board of Directors

 
The N2 Board of Directors consists of 12 individuals representing the different stakeholders within N2 membership.
Karen Arts

Karen Arts

Co-founder

Executive Director Canadian Cancer Clinical Trials Network (3CTN)
Jim Pankovich

Jim Pankovich

Chair

Vice President, Clinical Operations & Drug Development-Qu Biologics Inc.
Rachel Syme

Rachel Syme

Vice Chair

Assistant Director, Institute of Cancer Research, CIHR
Patrick Clifford

Patrick Clifford

Treasurer

Director of Research and Innovation, CreateIT Now @ Southlake Innovation Centre – The Research Institute at Southlake
Erin Cherban

Erin Cherban

Secretary

Chief Research Officer Centre for Health Evaluation & Outcome Sciences (CHÉOS), CIHR Canadian HIV Trials Network (CTN)

 

Linda Bennett

Linda Bennett

Board Member

Project Manager, Marvelle Koffler Breast Centre Research Program
Kathy Brodeur-Robb

Kathy Brodeur-Robb

Board Member

Executive Director C-17 Council
Lisa Johnston

Lisa Johnston

Board Member

Clinical Research Facilitator, Ottawa Hospital Research Institute (OHRI)

Tammy Mah-Fraser

Tammy Mah-Fraser

Board Member

Director, Platform Operations – Alberta Innovates – Health Solutions
Janette Panhuis

Janette Panhuis

Board Member

Chief Operating Officer of the Population Health Research Institute, A Joint Institute of HHS and McMaster University